[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients
Clinical trial NCT05222269 · TERMINATED
Trial details
- NCT number
- NCT05222269
- Sponsor
- Pentixapharm AG
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-05
- Primary completion
- 2023-01-25
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.